Department of Neurological Surgery, Cleveland Clinic, Neurological Institute, Cleveland, Ohio, USA.
J Neurointerv Surg. 2013 Mar;5(2):117-20. doi: 10.1136/neurintsurg-2012-010258. Epub 2012 Jan 27.
Device developments and evolution in technique over the past decade make the treatment of aneurysms which were previously considered poor candidates for coiling more feasible. The authors describe their experience treating aneurysms at a single high-volume tertiary care center, focusing particularly on the use of adjunctive devices.
A retrospective review was undertaken of all the aneurysms treated at the Cleveland Clinic between 2003 and 2010.
A total of 1455 aneurysms were treated (45% subarachnoid hemorrhage). In 2003, aneurysms were treated equally with clipping (49.6%) and coiling (50.4%). Over the 8-year period reviewed there was a decline in the percentage of aneurysms treated surgically. By 2010, 25.5% of aneurysms were treated surgically and 74.5% by endovascular coiling. Among aneurysms that were coiled there was an increase in the cases treated with adjuncts including balloon remodeling and stents. The most dramatic increase in the relative proportion of a single method was the more widespread use of the combined 'balloon stent' technique. Initially used in 12% of stent-assisted cases, it is currently employed in 35.4% of cases.
Significant changes in practice trends for aneurysm treatment have been observed at a single high-volume tertiary care center over the past decade. Although these changes are multifactorial, they are explained in part by institutional comfort level with the adoption of adjunctive techniques, with a growing number of aneurysms treated with balloon remodeling and the 'balloon stent' technique.
过去十年中,器械的发展和技术的进步使得以前被认为不适合进行线圈栓塞治疗的动脉瘤的治疗变得更加可行。作者描述了他们在一家高容量的三级护理中心治疗动脉瘤的经验,特别关注辅助器械的使用。
回顾性分析了克利夫兰诊所 2003 年至 2010 年间治疗的所有动脉瘤。
共治疗了 1455 个动脉瘤(45%为蛛网膜下腔出血)。2003 年,夹闭术(49.6%)和线圈栓塞术(50.4%)治疗动脉瘤的比例相等。在回顾的 8 年期间,手术治疗的动脉瘤比例下降。到 2010 年,25.5%的动脉瘤采用手术治疗,74.5%采用血管内线圈栓塞治疗。在接受线圈栓塞治疗的动脉瘤中,使用辅助器械(包括球囊重塑和支架)的病例有所增加。单一方法的相对比例增加最多的是更广泛地使用联合“球囊支架”技术。最初在 12%的支架辅助病例中使用,目前在 35.4%的病例中使用。
过去十年,一家高容量的三级护理中心观察到动脉瘤治疗实践趋势发生了重大变化。尽管这些变化是多因素的,但部分原因是机构对辅助技术的采用感到舒适,越来越多的动脉瘤采用球囊重塑和“球囊支架”技术治疗。